Cargando…

Vascular peroxidase 1 is independently associated with worse kidney function in patients with peripheral artery disease

BACKGROUND: Oxidative stress is involved in cardiovascular disease such as peripheral artery disease (PAD). Vascular Peroxidase 1 (VPO1), a novel heme-containing peroxidase mainly expressed in the cardiovascular system, aggravates oxidative stress. Evidence in humans is limited. Current work aims to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Costas, Lavinia, Herz, Carsten Thilo, Höbaus, Clemens, Koppensteiner, Renate, Schernthaner, Gerit-Holger
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881961/ https://www.ncbi.nlm.nih.gov/pubmed/32813143 http://dx.doi.org/10.1007/s40620-020-00818-w

Ejemplares similares

Peripheral arterial disease and type 2 diabetes: Older patients still exhibit a survival benefit from glucose control
por: Höbaus, Clemens, et al.
Publicado: (2020)

Thrombospondin-4 increases with the severity of peripheral arterial disease and is associated with diabetes
por: Zierfuss, Bernhard, et al.
Publicado: (2019)

Angiogenin—A Proposed Biomarker for Cardiovascular Disease—Is Not Associated With Long-Term Survival in Patients With Peripheral Artery Disease
por: Höbaus, Clemens, et al.
Publicado: (2021)

NT-proBNP as a surrogate for unknown heart failure and its predictive power for peripheral artery disease outcome and phenotype
por: Zierfuss, Bernhard, et al.
Publicado: (2023)

Soluble urokinase-type plasminogen activator receptor predicts peripheral artery disease severity and outcomes
por: Höbaus, Clemens, et al.
Publicado: (2021)

Fetuin-A Levels Are Increased in Patients With Type 2 Diabetes and Peripheral Arterial Disease
por: Lorant, David Peter, et al.
Publicado: (2011)

Endothelial Progenitor Cells Are Related to Glycemic Control in Children With Type 1 Diabetes Over Time
por: Hörtenhuber, Thomas, et al.
Publicado: (2013)

YKL-40 and its complex association with metabolic syndrome, obesity, and cardiovascular disease
por: Schernthaner, Gerit-Holger, et al.
Publicado: (2016)

Decrease of dipeptidyl peptidase 4 activity is associated with weight loss after bariatric surgery
por: Herz, Carsten T., et al.
Publicado: (2021)

Do We Still Need Pioglitazone for the Treatment of Type 2 Diabetes? A risk-benefit critique in 2013
por: Schernthaner, Guntram, et al.
Publicado: (2013)

The effects of GLP-1 analogues, DPP-4 inhibitors and SGLT2 inhibitors on the renal system
por: Schernthaner, Guntram, et al.
Publicado: (2014)

Individualisierung der antihypertensiven Therapie bei Patient:innen mit Diabetes mellitus. Leitlinie der Österreichischen Diabetes Gesellschaft (Update 2023)
por: Saely, Christoph H., et al.
Publicado: (2023)

Cure of Type 2 Diabetes by Metabolic Surgery? A Critical Analysis of the Evidence in 2010
por: Schernthaner, Guntram, et al.
Publicado: (2011)

Renal Function but Not Asymmetric Dimethylarginine Is Independently Associated with Retinopathy in Type 2 Diabetes
por: Krzyzanowska, Katarzyna, et al.
Publicado: (2011)

The importance of socio-economic determinants of health in the care of patients with peripheral artery disease: A narrative review from VAS
por: Kolossváry, Endre, et al.
Publicado: (2023)

Independent evolution of four heme peroxidase superfamilies
por: Zámocký, Marcel, et al.
Publicado: (2015)

Peripheral arterial disease in the Middle East: Underestimated predictor of worse outcome
por: El-Menyar, Ayman, et al.
Publicado: (2013)

Involvement of APOE in Incidence of Revascularization in Patients Affected by Peripheral Arterial Disease: A Prospective Study from Southern Italy
por: Di Stolfo, Giuseppe, et al.
Publicado: (2023)

To the editor regarding article “Coadministration of DPP-4 inhibitor and insulin therapy does not further reduce the risk of cardiovascular events compared with DPP-4 inhibitor therapy in diabetic foot patients: a nationwide population-based study”
por: Mayer, Florian J., et al.
Publicado: (2018)

Micro- and Macrovascular Effects of Inflammation in Peripheral Artery Disease—Pathophysiology and Translational Therapeutic Approaches
por: Poledniczek, Michael, et al.
Publicado: (2023)

Peripheral Vascular Dysfunction in Chronic Kidney Disease
por: Martens, Christopher R., et al.
Publicado: (2011)

Peripheral Oxidation Markers in Down Syndrome Patients: The Better and the Worse
por: Szwajgier, Dominik, et al.
Publicado: (2021)

Optimal therapeutic strategy for those with chronic kidney disease and peripheral artery disease receiving peripheral vascular intervention
por: Imamura, Teruhiko
Publicado: (2020)

Moderately hyperglycemia as an independent prognostic factor for the worse outcome of COVID-19
por: Nateghi, Saeed, et al.
Publicado: (2022)

Worse and Worse and Worse: Essential Tremor Patients’ Longitudinal Perspectives on Their Condition
por: Gutierrez, Jesús, et al.
Publicado: (2016)

Receptor-Mediated and Fluid-Phase Transcytosis of Horseradish Peroxidase across Rat Hepatocytes
por: Ellinger, Isabella, et al.
Publicado: (2010)

HISTOCHEMICAL STUDIES ON THE UPTAKE OF HORSERADISH PEROXIDASE BY RAT KIDNEY SLICES
por: Miller, A. T., et al.
Publicado: (1965)

BIDIRECTIONAL TRANSPORT OF HORSERADISH PEROXIDASE IN PROXIMAL TUBULE OF NECTURUS KIDNEY
por: Bentzel, C. J., et al.
Publicado: (1971)

Biomarkers of Neutrophil Activation in Patients with Symptomatic Chronic Peripheral Artery Disease Predict Worse Cardiovascular Outcome
por: Buso, Giacomo, et al.
Publicado: (2023)

Arabidopsis APx-R Is a Plastidial Ascorbate-Independent Peroxidase Regulated by Photomorphogenesis
por: Lazzarotto, Fernanda, et al.
Publicado: (2021)

Frailty is independently associated with worse health-related quality of life in chronic kidney disease: a secondary analysis of the Frailty Assessment in Chronic Kidney Disease study
por: Nixon, Andrew C, et al.
Publicado: (2019)

Frailty is independently associated with worse health-related quality of life in chronic kidney disease: a secondary analysis of the Frailty Assessment in Chronic Kidney Disease study
por: Nixon, Andrew C, et al.
Publicado: (2019)

Frailty is independently associated with worse health-related quality of life in chronic kidney disease: a secondary analysis of the Frailty Assessment in Chronic Kidney Disease study
por: Nixon, Andrew C, et al.
Publicado: (2020)

Impaired fornix–hippocampus integrity is linked to peripheral glutathione peroxidase in early psychosis
por: Baumann, P S, et al.
Publicado: (2016)

Comparison of Aggregometry with Flow Cytometry for the Assessment of Agonists´-Induced Platelet Reactivity in Patients on Dual Antiplatelet Therapy
por: Gremmel, Thomas, et al.
Publicado: (2015)

Sleep apnea is not associated with worse outcomes in kidney transplant recipients
por: Fornadi, Katalin, et al.
Publicado: (2014)

Severe Retinopathy of Prematurity Is Not Independently Associated With Worse Neurodevelopmental Outcomes in Preterm Neonates
por: Altendahl, Marie, et al.
Publicado: (2021)

Permanent pacemaker placement following valve surgery is not independently associated with worse outcomes
por: Bianco, Valentino, et al.
Publicado: (2021)

Critical role of vascular peroxidase 1 in regulating endothelial nitric oxide synthase
por: Liu, Zhaoya, et al.
Publicado: (2017)

Severe acute kidney disease is associated with worse kidney outcome among acute kidney injury patients
por: Chen, Yu-Wei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dj2f2gdp0vkhbn94d06st7kdrd